Streetbeat News

Equity Actions

HASI

Hannon Armstrong (NYSE:HASI) received mixed ratings from 5 analysts in the past three months, with an average 12-month price target of $27.8, down from the previous $30.00. The ratings range from 'Buy' to 'Neutral' with price targets varying from $23.00 to $31.00. The company specializes in financing energy-efficiency and renewable-energy projects. Despite a strong net margin of 43.08%, Hannon Armstrong faces revenue challenges with a 19.35% decline and a lower than average ROE of 1.06%. The company's debt-to-equity ratio is 1.78, indicating a balanced approach to debt management.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 9:00 pm

LBPH

Longboard Pharmaceuticals Inc (NASDAQ:LBPH) stock fell by 11.3% to $22.26 after announcing a $150 million underwritten public offering. The company may also grant underwriters a 30-day option to purchase up to an additional $22.5 million of shares. Cantor and Citigroup are leading the offering, with Wedbush PacGrow and H.C. Wainwright & Co. as lead managers. There is no certainty on the completion or terms of the offering. LBPH's 52-week range is $3.60 to $26.50.

Portfolio Pulse from Henry Khederian

January 03, 2024 | 8:59 pm

HAL

Halliburton (NYSE:HAL) has seen a 26.42% increase in short interest since its last report, with 19.29 million shares sold short, representing 2.44% of its float. The short interest is below the peer group average of 7.01%. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop. It takes traders approximately 2.26 days to cover their short positions based on current trading volume.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 8:30 pm

AMP

BX

CME

RJF

SCHW

STT

Goldman Sachs analyst Alexander Blostein revised ratings on several asset management stocks, downgrading Blackstone Inc (BX), Charles Schwab Corp (SCHW), and Raymond James Financial Inc (RJF) to Neutral, and CME Group Inc (CME) to Sell. Upgrades were given to State Street Corporation (STT) and Ameriprise Financial Inc (AMP) to Buy. The sector is expected to see a more constructive EPS growth trajectory in 2024, with a wider dispersion in share price performance.

Portfolio Pulse from Lekha Gupta

January 03, 2024 | 8:02 pm

MELI

MercadoLibre (NASDAQ:MELI) received diverse analyst ratings in the last three months, with 1 bullish and 3 somewhat bullish ratings. The average 12-month price target for MELI is $1762.5, reflecting an 8.46% increase from the previous target of $1625. Analysts from Citigroup, Wedbush, and Susquehanna have raised their price targets, indicating positive sentiment towards the company's performance. MercadoLibre operates the largest e-commerce marketplace in Latin America and has shown strong financial indicators such as a 39.78% revenue growth rate, a net margin of 9.55%, an ROE of 14.38%, an ROA of 2.29%, and a debt-to-equity ratio of 1.91.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 8:01 pm

DRI

Darden Restaurants (NYSE:DRI) has been rated by 12 analysts in the last three months, with a mix of bullish and somewhat bullish perspectives. The average 12-month price target is $172.5, up from $166.25, with a high of $190.00 and a low of $155.00. Analysts from firms like Barclays, Oppenheimer, and Truist Securities have updated their ratings and price targets, reflecting their views on the company's market performance and financial health. Darden Restaurants, a major U.S. full-service restaurant operator, has faced a slight revenue decline of -0.12% over 3 months but maintains strong profitability with a net margin of 7.78% and an ROE of 10.13%, despite a high debt-to-equity ratio of 2.71.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 8:00 pm

WW

There was a notable options market activity for WW International, with a sweep of 2,877 call options at a strike price of $8.5, expiring on January 19th, traded at $0.45 each. This was against an open interest of 86, indicating new positioning. The stock reference price at the time was $7.79.

Portfolio Pulse from Charles Gross

January 03, 2024 | 7:48 pm

LBPH

Longboard Pharmaceuticals (LBPH) shares dropped following the announcement of a $150 million underwritten public offering, with an additional $22.5 million option for underwriters. The offering dilutes current shareholders, leading to the stock price decline.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 7:05 pm

CHRD

Chord Energy (NASDAQ:CHRD) received mixed analyst ratings with 2 bullish and 3 somewhat bullish over the past three months. The average 12-month price target is $189.8, down from the previous $196.00. Analysts from Mizuho, RBC Capital, Stifel, Piper Sandler, and Wells Fargo provided updates, with price target adjustments reflecting recent market conditions and company performance. Chord Energy's financials show a revenue decline of -5.51% over 3 months, a high net margin of 18.54%, a below-average ROE of 4.27%, an above-average ROA of 3.09%, and a low debt-to-equity ratio of 0.11.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 7:01 pm

SHLS

Shoals Technologies Group Inc (NASDAQ:SHLS) has received 11 analyst ratings in the last three months, with sentiments ranging from bullish to bearish. The average 12-month price target is $24.82, with a high of $33.00 and a low of $17.00, reflecting a 6.09% decrease from the previous average. Analysts have adjusted their ratings and price targets in response to market conditions and company performance. Shoals Technologies Gr specializes in EBOS solutions for solar energy projects and has recently entered the electric vehicle charging market. The company's financials show a revenue growth of 47.77% as of September 30, 2023, but it faces challenges with below-average ROE and ROA, despite efficient cost management and a conservative debt approach.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 7:01 pm